Aim To investigate the usage of chest computed tomography (CT) scan score for improvement in diagnostic and treatment efficacy of repetitive pleural effusion. Methods CT scan scoring system was used as a part of diagnostic procedures in patients with repetitive pleural effusion. Patients with at least two pleurocentesis were included in the study. Chest and abdominal ultrasound, chest x-ray, bronchoscopy, biochemical, microbiological and cytological analysis of pleural fluid specimen were performed for all patients. Results In a two-year period (during 2017-2018) 79 patients were analysed, 27 (34.17%) female and 52 (65.82%) male patients. Malignant pleural diseases were confirmed in 32 cases (40.5%), nonmalignant pleural effusions in 38 (48.1 %) cases, and nine (11.4%) patients rested without exact cause of pleural effusion after two pleurocenteses. Binary regression model showed odds ratio of 1.314; CI 95% 1.119-1.543) (p=0.00088). Confirmed malignancies with pleural effusion were in high correlation with the number of points in CT scan score. Conclusion CT scan scoring system was helpful for diagnostic and treatment decision making in patients with repetitive pleural effusion.
Jany B, Welte T. Pleural effusion in adults-etiology, diagnosis, and treatment. Dtsch ArzteblInt. 2019. p. 377–86.
2.
Höfken H, Herrmann D, Ewig S, Volmerig J, Hecker E. Video-assisted thoracoscopic surgery of parapneumonic empyema -10-year single-centre experience. Pneumologie. 2018. p. 843–50.
3.
Saguil A, Wryck K, Hallgren J. Diagnostic approach to pleural effusion. Am Fam Physician. 2014. p. 99–100.
4.
Romero Candeira S, Hernández L, Brufao R, Orts S, Fernández D, Martín C, et al. Is it meaningful to use biochemical parameters to discriminate between transudative and exudative pleural effusions. Chest. 2002. p. 1505–6.
5.
Thoracicsociety A. Management of malignant pleural effusions. Am J Respir Crit Care Med. 2000. p. 1987–2001.
6.
Psallidas I, Kalomenidis I, Porcel J, Robinson B, Stathopoulos G. Malignant pleural effusion: from bench to bedside. Eur Respir Rev. 2016. p. 189–98.
7.
Bielsa S, Porcel J, Castellote J, Mas E, Esquerda A, Light R. Solvingthe Light’s criteria misclassification rate of cardiac and hepatic transudates. Respirology. 2012. p. 721–6.
8.
Boujaoude Z, Bartter T, Abboud M, Pratter M, Abouzgheib W. Pleuroscopic pleurodesis combined with tunneled pleural catheter for management of malignant pleural effusion: a prospective observational study. J Broncol Interv Pulmonol. 2015. p. 237–43.
9.
Clive A, Jones H, Bhatnagar R, Preston N, Maskell N. Interventions for the management of malignant pleural effusions: a network meta-analysis. 2016.
10.
Salamonsen M, Lo A, Ng A, Bashirzadeh F, Wang W, Fielding D. Novel use of pleural ultrasound can identify malignant entrapped lung prior to effusion drainage. Chest. 2014. p. 1286–93.
11.
Bielsa S, Pardina M, Gonzalez A, Porcel J. A computed tomography score to predict malignant pleural effusion. Eur Respir J. 2013.
12.
Porcel J, Pardina M, Bielsa S, González A, Light R. Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusion. Chest. 2015. p. 513–9.
13.
Moy M, Levsky J, Berko N, Godelman A, Jain V, Haramati L, et al. simple method for estimating pleural effusion size on CT scans. Chest. 2013. p. 1054–9.
14.
Ferreira A, Filho F, Braga T, Fanstone G, Chabrel I, Chodraiub, et al. The role of ultrasound in the assessment of pleural effusion. Radiol Bras. 2006. p. 145–50.
15.
Mcgrath E, Anderson P. Diagnosis of pleural effusion: a systematic approach. Am J Crit Care. 2011. p. 119–27.
16.
Kastelik J. Management of malignant pleural effusion. Lung. 2013. p. 165–75.
17.
Soni N, Franco R, Velez M, Schnobrich D, Dancel R, Restrepo M, et al. Ultrasound in the diagnosis and management of pleural effusions. J Hosp Med. 2015. p. 811–6.
18.
Lichtenstein D. Lung ultrasound in acute respiratory failure an introduction to the BLUE-protocol. Anestesiologica. 2009. p. 313–7.
19.
Kalokairinou-Motogna M, Maratou K, Paianid I, Soldatos T, Antipa E, Tsikini A, et al. Application of color Doppler ultrasound in the study of small pleural effusion. Med Ultrason. 2010. p. 12–6.
20.
Grimberg A, Shigueoka D, Atallah A, Ajzen S, Iared W. Diagnostic accuracy of sonography for pleural effusion: systematic review. Sao Paulo Med J. 2010. p. 90–5.
21.
Lichtenstein D. Lung ultrasound in the critically ill. Ann Intensive Care. 2014. p. 2–12.
22.
Volpicelli G, Elbarbary M, Blaivas M, Volpicelli G, Elbarbary M, Blaivas M, et al. International evidence-based recommendations for point-of-care lung ultrasound. Inten Care Med. 2012. p. 577–91.
23.
Chian C, Su W, Soh L, Yan H, Perng W, Wu C. Echogenic swirling pattern as a predictor of malignant pleural effusions in patients with malignancies. Chest. 2004. p. 129–34.
24.
Chen K, Liaw Y, Wang H, Luh K, Yang P. Sonographic septation: a useful prognostic indicator of acute thoracic empyema. J Ultrasound Med. 2000. p. 837–43.
25.
Feller-Kopman D, Light R, Disease. N Engl J Med. 2018. p. 740–75.
26.
Xirouchaki N, Kondili E, Prinianakis G, Malliotakis P, Georgopoulos D. Impact of lung ultrasound on clinical decision making in critically ill patients. Inten Care Med. 2014. p. 57–65.
27.
Ahmed L, Ip H, Rao D, Patel N, Noorzad F. Talc pleurodesis through indwelling pleural catheters for malignant pleural effusions: retrospective case series of a novel clinical pathway. Chest. 2014. p. 190–4.
28.
Putnam J, Light R, Rodriguez R, Ponn R, Olak J, Pollak J, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999. p. 1992–9.
29.
Grosu H, Molina S, Rhergott C, Najib M Rahman I, Psallidas. proceedings of American Thoracic Society International Conference.
30.
Anevlavis S, Kouliatsis G, Sotiriou I, Koukourakis M, Archontogeorgis K, Karpathiou G, et al. Prognostic factors in patients presenting with pleural effusion revealing malignancy. Respiration. 2014. p. 311–6.
31.
Simoff M, Lally B, Slade M, Goldberg W, Lee P, Michaud G, et al. Symptom management in patients with lung cancer -diagnosis and management of lung cancer. Chest. American; 2013. p. 455–97.
32.
Clive A, Kahan B, Hooper C, Bhatnagar R, Morley A, Zahan-Evans N, et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax. 2014. p. 1098–104.
33.
Usui K, Sugawara S, Nishitsuji M, Fujita Y, Inoue A, Mouri A, et al. A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013. Lung Cancer. 2016. p. 131–6.
34.
Yoon D, Cho J, Choi Y, Yong S, Jhingook K, Kim H, et al. Predictors of survival in patients who underwent video-assisted thoracic surgery talc pleurodesis for malignant pleural effusion. Thorac Cancer. 2016. p. 393–8.
35.
Ferreiro L, Suárez-Antelo J, Valdés L. Pleural procedures in the management of malignant effusions. Ann Thorac Med. 2017. p. 3–10.
36.
Clay R, Kipp B, Jenkins S, Karwoski R, Maldonado F, Rajagopalan S, et al. Computer-Aided Nodule Assessment and Risk Yield (CANARY) may facilitate non-invasive prediction of EGFR mutation status in lung adenocarcinomas. Sci Rep. 2017. p. 17620–30.
37.
Varghese C, Rajagopalan S, Karwoski R, Bartholomai B, Maldonado F, Boland J, et al. Computer tomography-based score indicative of lung cancer aggression (SILA) predict the degree of histological tissue invasion and patient survival in lung adenocarcinoma spectrum. J Thoracic Oncol. 2019. p. 1419–29.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
